Panmedica S.a.

Panmedica

S. A. Panmedica

Other

Laboratoires Panmedica

Marcel Lepant

Claude Laruelle

Bernard Raynier

3,3,5-trimethylcyclohexyl 2-methylpropionate derivatives, their method

Amino acid esters of cycloaliphatic alcohols of the formula: ##STR1## wherein A is cyclohexyl, cyclohexenyl, cyclopentyl, or cyclopentenyl, substituted with from one to three radicals selected from the group consisting of methyl, ethyl and ethenyl. These compounds are useful in treating lipemic disorders.

Amino acid esters of cycloaliphatic alcohols and their use in treating

Amino acid esters of cycloaliphatic alcohols of the formula: ##STR1## wherein A is cyclohexyl, cyclohexenyl, cyclopentyl and cyclopentenyl, substituted with from one to three radicals which are methyl, ethyl, and/or ethenyl. These amino acid esters have hypolipemic properties.

Amino acid of cycloaliphatic alcohols, process for their preparation and

Drugs with high anticonvulsant and analgesic activities constituted by symmetrical .beta.-dialkoxyiminocycloalklene derivatives in which the imine double bonds are conjugated with the cyclic double bond or bonds belonging to one or more fused benzene rings. They correspond to the general formula I: ##STR1##

Symmetrical O-substituted dioximes of benzo-fused

Alkylcarboxamides of pyridylalkylamines, useful in human and verterinary medicine, correspond to the general formula I: ##STR1## wherein n=0 or 1,

Alkylcarboxamides of pyridylalkylamines, and their use in human and

The present invention relates to novel antibacterial agents, corresponding to the following general formula I ##STR1## in which: Q represents an aromatic ring,

Antibacterial agents containing oxo-4-pyridine carboxylic acid

The present invention relates to new adamantanamine derivatives. These derivatives correspond to the general formula I: ##STR1## in which: R represents hydrogen or a substituted or unsubstituted, linear or branched alkyl radical containing from 1 to 7 carbon atoms. Drugs possessing anticonvulsant properties.

Adamantanamine derivatives, processes for their preparation and drugs in

The present invention relates to new N-acyl derivatives of amino acids. These derivatives correspond to the general formula I below: ##STR1## in which A represents a linear or branched, saturated hydrocarbon radical containing from 1 to 6 carbon atoms or a saturated ring containing 6 carbon atoms,

N-acyl derivatives of amino acids and their esters, and drugs in which

Derivatives of 2-[3-(3-indolyl 2-amino propionyloxy] acetic acid corresponding to the following general formula I: ##STR1## in which R represents a hydrogen atom, a linear or branched alkyl radical including 1 to 12 carbon atoms, or a mono-alicyclic or polycyclic radical containing 5 to 16 carbon atoms, possibly linked by a methylene radical, and their pharmaceutically acceptable addition salts, are useful as medicaments for palliating deficiency of the serotoninergic system.

Processes for the preparation of derivatives of 2-[3-(3-indolyl) 2-amino

The present invention relates to new dipeptides of L-5-hydroxytryptophan. They correspond to the general formula below: ##STR1## in which: X represents hydrogen or a lower acyl radical and

Dipeptides of L-5-hydroxytryptophan, processes for their preparation and

A pharmaceutical composition suitable for increasing cerebral serotonin concentration, comprising a serotonin precursor selected from the group consisting of 5-hydroxytryptophan and derivatives of 5-hydroxytryptophan having the formula: ##STR1## wherein R represent hydrogen; a C.sub.1 -C.sub.12 alkyl group; or a C.sub.5 -C.sub.16 alicyclic, monocyclic aromatic hydrocarbyl, or polycyclic aromatic hydrocarbyl group; and a nitrogenous heterocyclic compound selected from the group consisting of inosine, theophylline, theobromine, allopurinol, pyridoxine, hypoxanthine, folic acid, adenine, nicotinamide, caffeine, and orotic acid.

Pharmaceutical compositions capable of increasing cerebral serotonin

Derivatives of 2-[3-(3-indoly)2-amino propionyloxy] acetic acid, and

The present invention relates to novel soluble N.sub.2 substituted derivatives of 2,4-diamino 5-benzyl pyrimidines. These derivatives correspond to the general formula III below: ##STR1## The novel soluble N.sub.2 substituted derivatives are powerful antibacterial agents.

Growing community of inventors

Vence, France

Marcel Lepant